Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of Summary of Options Granted to Purchase

v3.23.3
Stockholders Equity (Details) - Schedule of Summary of Options Granted to Purchase - Stock Option [Member]
$ / shares in Units, $ in Thousands
 9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Stockholders Equity (Details) - Schedule of Summary of Options Granted to Purchase [Line Items]  
Number of Options, Outstanding at the beginning of period 4,769,441
Weighted Average Exercise Price, Outstanding at the beginning of period (in Dollars per share) | $ / shares $ 2.93
Aggregate Intrinsic Value, Outstanding at the beginning of period (in Dollars) | $ $ 40
Number of Options, Granted 1,625,000
Weighted Average Exercise Price, Granted (in Dollars per share) | $ / shares $ 0.4
Number of Options, Forfeited (329,860)
Weighted Average Exercise Price, Forfeited (in Dollars per share) | $ / shares $ 2.32
Number of Options Expired (154,245)
Weighted Average Exercise Price, Expired (in Dollars per share) | $ / shares $ 4.69
Number of Options, Exercised
Weighted Average Exercise Price, Exercised (in Dollars per share) | $ / shares
Number of Options, Outstanding at the end of period 5,910,336
Weighted Average Exercise Price, Outstanding at the end of period (in Dollars per share) | $ / shares $ 2.22
Aggregate Intrinsic Value, Outstanding at the end of period (in Dollars) | $ $ 76
Number of Options, Exercisable at end of period 3,234,658
Weighted Average Exercise Price, Exercisable at the end of period 3.02
Weighted average remaining contractual life of outstanding options – years as of June 30, 2023 7 years 10 days